Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$40.25 - $52.99 $80 - $105
2 Added 1.75%
116 $4,000
Q1 2024

Jul 17, 2024

BUY
$47.98 - $54.4 $47 - $54
1 Added 0.88%
114 $6,000
Q4 2023

Jul 17, 2024

SELL
$48.48 - $57.85 $2,666 - $3,181
-55 Reduced 32.74%
113 $5.79 Million
Q3 2023

Jul 17, 2024

BUY
$57.89 - $64.73 $57 - $64
1 Added 0.6%
168 $9.78 Million
Q2 2023

Jul 17, 2024

BUY
$63.71 - $70.74 $63 - $70
1 Added 0.6%
167 $10.7 Million
Q1 2023

Jul 17, 2024

BUY
$65.71 - $74.53 $131 - $149
2 Added 1.22%
166 $11.5 Million
Q4 2022

Jul 17, 2024

SELL
$68.48 - $81.09 $2,876 - $3,405
-42 Reduced 20.39%
164 $11.8 Million
Q3 2022

Jul 17, 2024

BUY
$0.13 - $76.84 $0 - $76
1 Added 0.49%
206 $14.7 Million
Q2 2022

Jul 17, 2024

BUY
$72.62 - $79.98 $5,083 - $5,598
70 Added 51.85%
205 $15.8 Million
Q1 2022

Jul 17, 2024

SELL
$61.48 - $73.72 $1,291 - $1,548
-21 Reduced 13.46%
135 $9.88 Million
Q3 2021

Jul 17, 2024

SELL
$59.17 - $69.31 $877,372 - $1.03 Million
-14,828 Reduced 98.96%
156 $9.22 Million
Q2 2021

Jul 17, 2024

BUY
$61.91 - $67.42 $913,791 - $995,119
14,760 Added 6589.29%
14,984 $224,000
Q1 2021

Jul 17, 2024

SELL
$59.34 - $66.74 $652 - $734
-11 Reduced 4.68%
224 $14.1 Million
Q4 2020

Jul 17, 2024

BUY
$57.74 - $65.43 $692 - $785
12 Added 5.38%
235 $14.6 Million
Q3 2020

Jul 17, 2024

SELL
$57.43 - $63.64 $7,121 - $7,891
-124 Reduced 35.73%
223 $13.4 Million
Q2 2020

Jul 17, 2024

SELL
$54.82 - $64.09 $1,754 - $2,050
-32 Reduced 8.44%
347 $20.4 Million
Q1 2020

Jul 17, 2024

SELL
$46.4 - $67.43 $1,160 - $1,685
-25 Reduced 6.19%
379 $21.2 Million
Q4 2019

Jul 17, 2024

BUY
$49.21 - $64.19 $7,430 - $9,692
151 Added 59.68%
404 $25.9 Million
Q2 2019

Jul 17, 2024

BUY
$44.62 - $49.34 $937 - $1,036
21 Added 9.05%
253 $11.5 Million
Q1 2019

Jul 17, 2024

BUY
$45.12 - $53.8 $10,467 - $12,481
232 New
232 $11.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.